A detailed history of Good Life Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Good Life Advisors, LLC holds 26,174 shares of ABT stock, worth $3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
26,174
Previous 24,895 5.14%
Holding current value
$3 Million
Previous $2.59 Million 15.39%
% of portfolio
0.19%
Previous 0.22%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$100.07 - $118.13 $127,989 - $151,088
1,279 Added 5.14%
26,174 $2.98 Million
Q2 2024

Jul 17, 2024

SELL
$100.73 - $112.44 $3,122 - $3,485
-31 Reduced 0.12%
24,895 $2.59 Million
Q1 2024

May 02, 2024

SELL
$109.52 - $120.96 $2,628 - $2,903
-24 Reduced 0.1%
24,926 $2.83 Million
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $4,058 - $4,968
45 Added 0.18%
24,950 $2.75 Million
Q3 2023

Oct 19, 2023

BUY
$95.53 - $114.62 $1.79 Million - $2.15 Million
18,768 Added 305.82%
24,905 $2.41 Million
Q2 2023

Jul 10, 2023

BUY
$100.78 - $112.29 $127,184 - $141,709
1,262 Added 25.89%
6,137 $669,000
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $7,845 - $9,234
81 Added 1.69%
4,875 $493,000
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $4,753 - $5,576
50 Added 1.05%
4,794 $526,000
Q3 2022

Oct 13, 2022

SELL
$96.76 - $112.03 $3,193 - $3,696
-33 Reduced 0.69%
4,744 $459,000
Q2 2022

Jul 19, 2022

BUY
$102.07 - $123.37 $26,129 - $31,582
256 Added 5.66%
4,777 $519,000
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $5,244 - $6,395
46 Added 1.03%
4,521 $535,000
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $40,319 - $49,369
-349 Reduced 7.23%
4,475 $630,000
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $59,263 - $65,562
508 Added 11.77%
4,824 $570,000
Q2 2021

Jul 29, 2021

SELL
$105.79 - $124.53 $34,381 - $40,472
-325 Reduced 7.0%
4,316 $500,000
Q1 2021

Apr 27, 2021

BUY
$108.84 - $128.23 $26,339 - $31,031
242 Added 5.5%
4,641 $556,000
Q4 2020

Feb 04, 2021

SELL
$105.0 - $114.42 $2,625 - $2,860
-25 Reduced 0.57%
4,399 $482,000
Q3 2020

Oct 19, 2020

SELL
$91.64 - $111.29 $9,255 - $11,240
-101 Reduced 2.23%
4,424 $481,000
Q2 2020

Jul 20, 2020

BUY
$76.57 - $98.0 $46,248 - $59,192
604 Added 15.4%
4,525 $414,000
Q1 2020

May 01, 2020

SELL
$62.82 - $91.86 $3,706 - $5,419
-59 Reduced 1.48%
3,921 $310,000
Q4 2019

Jan 17, 2020

BUY
$78.51 - $87.4 $4,082 - $4,544
52 Added 1.32%
3,980 $347,000
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $3,109 - $3,372
-38 Reduced 0.96%
3,928 $329,000
Q2 2019

Aug 06, 2019

SELL
$72.88 - $85.0 $5,101 - $5,950
-70 Reduced 1.73%
3,966 $335,000
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $6,290 - $7,605
95 Added 2.41%
4,036 $324,000
Q4 2018

Feb 01, 2019

BUY
$65.56 - $74.27 $258,371 - $292,698
3,941 New
3,941 $285,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Good Life Advisors, LLC Portfolio

Follow Good Life Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Good Life Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Good Life Advisors, LLC with notifications on news.